BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37473966)

  • 1. Mebendazole targets essential proteins in glucose metabolism leading gastric cancer cells to death.
    da Silva EL; Mesquita FP; Aragão DR; de Sousa Portilho AJ; Marinho AD; de Oliveira LLB; Lima LB; de Moraes MEA; Souza PFN; Montenegro RC
    Toxicol Appl Pharmacol; 2023 Sep; 475():116630. PubMed ID: 37473966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anthelmintic drug mebendazole inhibits growth, migration and invasion in gastric cancer cell model.
    Pinto LC; Soares BM; Pinheiro Jde J; Riggins GJ; Assumpção PP; Burbano RM; Montenegro RC
    Toxicol In Vitro; 2015 Dec; 29(8):2038-44. PubMed ID: 26315676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mebendazole induces apoptosis via C-MYC inactivation in malignant ascites cell line (AGP01).
    Pinto LC; Mesquita FP; Soares BM; da Silva EL; Puty B; de Oliveira EHC; Burbano RR; Montenegro RC
    Toxicol In Vitro; 2019 Oct; 60():305-312. PubMed ID: 31207347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma.
    Younis NS; Ghanim AMH; Saber S
    Sci Rep; 2019 Dec; 9(1):19095. PubMed ID: 31836811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer.
    Nygren P; Fryknäs M; Agerup B; Larsson R
    J Cancer Res Clin Oncol; 2013 Dec; 139(12):2133-40. PubMed ID: 24135855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation.
    Blom K; Senkowski W; Jarvius M; Berglund M; Rubin J; Lenhammar L; Parrow V; Andersson C; Loskog A; Fryknäs M; Nygren P; Larsson R
    Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):199-210. PubMed ID: 28472897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC).
    Zhang F; Li Y; Zhang H; Huang E; Gao L; Luo W; Wei Q; Fan J; Song D; Liao J; Zou Y; Liu F; Liu J; Huang J; Guo D; Ma C; Hu X; Li L; Qu X; Chen L; Yu X; Zhang Z; Wu T; Luu HH; Haydon RC; Song J; He TC; Ji P
    Oncotarget; 2017 Feb; 8(8):12968-12982. PubMed ID: 28099902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness.
    Joe NS; Godet I; Milki N; Ain NUI; Oza HH; Riggins GJ; Gilkes DM
    Breast Cancer Res; 2022 Dec; 24(1):98. PubMed ID: 36578038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EFFECT OF THE ANTIPARASITIC DRUG MEBENDAZOLE ON CHOLANGIOCARCINOMA GROWTH.
    Sawanyawisuth K; Williamson T; Wongkham S; Riggins GJ
    Southeast Asian J Trop Med Public Health; 2014 Nov; 45(6):1264-70. PubMed ID: 26466412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers.
    Meco D; Attinà G; Mastrangelo S; Navarra P; Ruggiero A
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning.
    Aliabadi A; Haghshenas MR; Kiani R; Koohi-Hosseinabadi O; Purkhosrow A; Pirsalami F; Panjehshahin MR; Erfani N
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2379-2388. PubMed ID: 37837472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mebendazole is a potent inhibitor to chemoresistant T cell acute lymphoblastic leukemia cells.
    Wang X; Lou K; Song X; Ma H; Zhou X; Xu H; Wang W
    Toxicol Appl Pharmacol; 2020 Jun; 396():115001. PubMed ID: 32277947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mebendazole exhibits potent anti-leukemia activity on acute myeloid leukemia.
    He L; Shi L; Du Z; Huang H; Gong R; Ma L; Chen L; Gao S; Lyu J; Gu H
    Exp Cell Res; 2018 Aug; 369(1):61-68. PubMed ID: 29750898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mebendazole, an antiparasitic drug, inhibits drug transporters expression in preclinical model of gastric peritoneal carcinomatosis.
    Celestino Pinto L; de Fátima Aquino Moreira-Nunes C; Soares BM; Burbano RMR; de Lemos JAR; Montenegro RC
    Toxicol In Vitro; 2017 Sep; 43():87-91. PubMed ID: 28606429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer.
    Zhang L; Bochkur Dratver M; Yazal T; Dong K; Nguyen A; Yu G; Dao A; Bochkur Dratver M; Duhachek-Muggy S; Bhat K; Alli C; Pajonk F; Vlashi E
    Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):195-207. PubMed ID: 30196056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma.
    Simbulan-Rosenthal CM; Dakshanamurthy S; Gaur A; Chen YS; Fang HB; Abdussamad M; Zhou H; Zapas J; Calvert V; Petricoin EF; Atkins MB; Byers SW; Rosenthal DS
    Oncotarget; 2017 Feb; 8(8):12576-12595. PubMed ID: 28157711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis.
    Bai RY; Staedtke V; Rudin CM; Bunz F; Riggins GJ
    Neuro Oncol; 2015 Apr; 17(4):545-54. PubMed ID: 25253417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway.
    Limbu KR; Chhetri RB; Oh YS; Baek DJ; Park EY
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventative Effect of Mebendazole against Malignancies in Neurofibromatosis 1.
    Staedtke V; Gray-Bethke T; Riggins GJ; Bai RY
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32650362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity.
    Elmaaty AA; Darwish KM; Chrouda A; Boseila AA; Tantawy MA; Elhady SS; Shaik AB; Mustafa M; Al-Karmalawy AA
    ACS Omega; 2022 Jan; 7(1):875-899. PubMed ID: 35036753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.